DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 50 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $28,494,000 | -48.2% | 735,898 | -47.4% | 0.16% | -49.8% |
| Q2 2018 | $55,042,000 | +33.4% | 1,398,791 | -32.1% | 0.32% | +27.0% |
| Q1 2018 | $41,259,000 | -24.0% | 2,058,842 | -14.0% | 0.25% | -25.7% |
| Q4 2017 | $54,286,000 | +14.7% | 2,394,625 | -3.9% | 0.33% | +9.2% |
| Q3 2017 | $47,314,000 | – | 2,491,542 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |